Computerised trading - but could be buying in or selling out depending on what they want. Not exactly a level playing field for the average punter.
Behrenbruch is very direct in his communication, and I would expect we will see that from the board. He doesnt like trashy ASX Biotech announcements - so I would expect to see only substantive releases - although it is ultimately up to the Chairman.
